1. India Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Amkay Products Limited

Amkay Products Limited

BBSE:AMKAY
55.50
INR
-2.50
(-4.31%)
450.09MMarket Cap
Amkay Products Limited
BSE:AMKAY
(Bombay Stock Exchange)

Recent

price

55.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
2026
TTM
INR
47.02
42.17
32.19
35.89
45.54
48.55
- -
Revenue per Share
3.61
1.69
1.74
3.04
3.96
2.67
- -
Basic EPS, GAAP
2.52
-2.77
1.1
-1.61
-3.31
0.33
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
5.48
7.17
8.91
- -
27.8
30.47
30.47
Book Value per Share
5.48
7.17
8.91
- -
27.78
30.44
30.44
Tangible Book Value per Share
9
9
9
9
8
9
9
Basic Weighted Avg Shares
407
365
279
311
384
420
- -
Sales/Revenue/Turnover
10.82
5.89
8.83
8.93
8.59
7.05
- -
Operating Margin (%)
3
5
7
6
8
9
- -
Depreciation Expense
31
15
15
26
33
23
- -
Net Income, GAAP
25.13
27.91
35.39
24.88
22.32
27.88
- -
Effective Tax Rate (%)
7.68
4.02
5.42
8.47
8.7
5.5
- -
Profit Margin (%)
25
34
43
- -
125
143
143
Working Capital
14
35
33
- -
10
5
5
LT Debt
47
62
77
- -
241
264
264
Total Equity
- -
17.3
13.63
- -
- -
7.54
- -
Return on Invested Capital (%)
- -
20.95
15.72
- -
- -
8.9
- -
Return on Capital (%)
- -
26.81
21.69
- -
- -
9.16
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
ST Debt
16
11
34
LT Borrowings
10
8
5
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
344
407
450

Working Capital

INR

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
Total Current Assets
172
195
205
Cash, Cash Equivalents & STI
15
22
32
Accounts Receivable, Net
60
73
49
Inventories
81
79
96
Total Current Liabilities
47
44
62
Payables & Accruals
- -
- -
- -
ST Debt
16
11
34
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
9.6%
Free Cash Flow
- -
-121.06%
-110.31%
Net Income, GAAP
- -
4.03%
-30.78%
Sales/Revenue/Turnover
- -
2.11%
9.47%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
311
2025
- -
- -
384
2026
- -
- -
420

Semi-annual Earnings Per Share

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
3.04
2025
- -
- -
3.96
2026
- -
- -
2.67

Semi-annual Dividends Per Share

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Amkay Products Limited is an India-based medical devices and healthcare consumables manufacturing company engaged in the production, assembling, and marketing of a comprehensive portfolio of medical equipment, disposable healthcare supplies, and personal hygiene products. The company offers medical consumables and personal protection products, including face masks, surgeon caps, disposable examination gloves, surgeon gowns, plastic aprons, shoe covers, and drape sheets; diagnostic and monitoring devices, including digital thermometers, blood pressure monitors, pulse oximeters, nebulizers, and vaporizers; surgical and respiratory aids, including oxygen masks, suction units, and needle destroyers; and wound care and hygiene essentials, including surgical tapes, alcohol prep pads, adhesive bandages, and hand sanitizers. Amkay Products markets its products primarily under the proprietary Amkay brand, while also providing original equipment manufacturer and contract manufacturing services to government and private hospitals, nursing homes, diagnostic laboratories, clinics, and retail distribution channels across India. Founded in 2007 and headquartered in Thane, Maharashtra, India, the company operates dedicated manufacturing and assembly infrastructure to serve domestic healthcare demand. In May 2024, Amkay Products Limited completed its initial public offering on the BSE SME platform to fund the expansion of its manufacturing capabilities, invest in new machinery, support working capital requirements, and broaden its national distribution network.